Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.

1-Deoxynojirimycin/analogs & derivatives; Administration, Oral; Diabetes Mellitus, Type 2/drug therapy; Drug Therapy, Combination; Enzyme Inhibitors/administration & dosage/pharmacokinetics/therapeutic use; Glucosamine/administration & dosage/analogs & derivatives/pharmacokinetics/therapeutic use; Humans; Hypoglycemic Agents/administration & dosage/pharmacokinetics/therapeutic use; Imino Pyranoses; Intestinal Absorption; alpha-Glucosidases/antagonists & inhibitors

Disciplines :

Endocrinology, metabolism & nutrition
Pharmacy, pharmacology & toxicology

Author, co-author :

Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale

Lefebvre, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques

Language :

English

Title :

Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.

Publication date :

2002

Journal title :

Diabetes Care

ISSN :

0149-5992

eISSN :

1935-5548

Publisher :

American Diabetes Association, Alexandria, United States - Virginia

Volume :

Issue :

Pages :

247-8

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

http://care.diabetesjournals.org/

Available on ORBi :

since 08 May 2009

Statistics

Number of views

105 (2 by ULiège)

Number of downloads

215 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations